Key result
Diabetes is not linked to differences in five-year survival or MI rates after PCI.
Why the study?
Does the presence of diabetes influence five-year survival and myocardial infarction rates in patients who underwent percutaneous coronary intervention?
Cohort (n=720)
Does the presence of diabetes influence five-year survival and myocardial infarction rates in patients who underwent percutaneous coronary intervention?
In patients undergoing percutaneous coronary intervention who have well-controlled blood glucose, the presence of diabetes does not significantly worsen five-year survival or myocardial infarction rates.
No immediate change to post-PCI risk assessment by diabetes status; leaves open glycemic control effects on longer-term outcomes.
The incidence of diabetes is on a boom in the world. Coronary heart disease is the most common macrovascular complications of diabetes. Strict control of blood glucose levels contribute to the betterment of the patient and reduce the cost of treatment. The aim is to show the influence and significance of diabetes in the five-year outcomes in patients who underwent percutaneous coronary intervention Initially in the study included 800 patients who underwent percutaneous coronary angioplasty index. After the indexing procedure clinical monitoring is completed for 720 patients (90%) whose data after the completion of the follow-up period subjected to statistical analysis, which included descriptive statistics, a mutual comparison of the examined groups were used methods for testing the significance of differences numeric-factor analysis of variance (ANOVA) student's t test, rank sum test (Mann-Whitney U test) hi-square test. They were monitored and analyzed the parameters of cardiac status obtained on outpatient examinations, and data obtained by telephone contact with the patient. Patients involved in the study had a very good glycoregulation, therefore there were no statistically significant differences in the five-year outcomes after percutaneous coronary intervention. The study showed approximately equal distribution of the sexes patients who are suffering from diabetes, those with diabetes mellitus type 1 patients with type 2 diabetes. There is no significance in survival, no matter what the patient is suffering from diabetes, has no significance because of the small number of deaths. It is similar to myocardial infarction, no statistically significant differences between patients with diabetes and patients who do not suffer from diabetes in terms of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Stojanović et al. (2017) conducted a cohort in Percutaneous coronary intervention (n=720). Diabetes vs. No diabetes was evaluated on Five-year outcomes (survival and myocardial infarction). Diabetes was not associated with statistically significant differences in five-year survival or myocardial infarction rates among patients who underwent percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: